Clearmind Medicine CMND
Clearmind submits FDA recommendations
Foreign issuer report
- Form
- 6-K
- Filed
- Importance
- Routine
- Accession
- 0001213900-26-107425
- Submitted recommendations on psychedelic therapies
- Focused on non-hallucinogenic neuroplastogens
- Collaborated with FDA and U.S. government agencies
Written from the 6-K on EDGAR. Check the filing before you rely on it.
Similar companies
Same SIC code (2834) and public float not reported.